The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease
Title:
The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease
Author:
Forman, Mark Kleijn, Huub-Jan Dockendorf, Marissa Palcza, John Tseng, Jack Canales, Christina Egan, Michael Kennedy, Matthew Laterza, Omar Ma, Lei Scott, Jack Tanen, Michael Apter, Jeffrey Backonja, Miroslav Ereshefsky, Larry Gevorkyan, Hakop Jhee, Stanford Rynders, Rebecca Zari, Arian Bryan, Ellie Wagner, John Troyer, Matthew Stone, Julie